LAUNCH REGENERATIVE
WHAT WE TREAT

Ehlers-Danlos, treated like the whole-body problem it is.

Diagnosis-first regenerative care for hypermobile EDS, joint instability, and the connected body — from a physician who treats the cause, not the label.

A whole-body problem, treated like one

Hypermobile Ehlers-Danlos syndrome (hEDS) is a heritable connective-tissue disorder: the collagen that should hold your joints, skin, and organs together is built differently, so it doesn’t hold. That’s why it rarely stays in one place — joint instability, chronic pain, fatigue, and frequently POTS, dysautonomia, and mast cell activation (MCAS) all travel together.

Why it gets missed

hEDS doesn’t appear on a routine scan, and “too many things hurt” is easy to dismiss. The result is years of being told it’s anxiety or deconditioning while unstable joints quietly do damage. The first job here is to stop dismissing and start measuring.

Diagnosis first — the whole kinetic chain

Dr. Paul reads the connected system, not one sore joint in isolation: dynamic ultrasound, exam, and the way one unstable link loads the next. In hypermobile bodies, the cause is often a long way from the pain.

Where regenerative medicine fits

For some patients, image-guided regenerative treatments can help stabilize and support specific unstable joints — applied judiciously, anchored in evidence, and individualized. This is not a cure for EDS; it is a way to make a fragile system more stable, joint by joint, as part of a larger plan.

The comorbidities, coordinated

EDS rarely travels alone. Care is coordinated with a specialist team for the POTS / dysautonomia / MCAS triad, and includes evaluation and referral planning for craniocervical and atlantoaxial instability (CCI / AAI) — the parts most clinics won’t touch.

Common questions

What is hypermobile Ehlers-Danlos syndrome (hEDS)?

hEDS is a heritable connective-tissue disorder — the collagen that should hold your joints, skin, and organs together is built differently, so it doesn’t hold. That’s why it rarely stays in one place: joint instability, chronic pain, and fatigue are common, and POTS, dysautonomia, and mast cell activation (MCAS) frequently travel alongside it.

Why does hEDS often get missed or dismissed?

hEDS doesn’t appear on a routine scan, and “too many things hurt” is easy to dismiss. The result is often years of being told it’s anxiety or deconditioning while unstable joints quietly do damage — which is why the first job is to stop dismissing and start measuring.

Why does care here also address POTS, dysautonomia, and MCAS?

EDS rarely travels alone. Care is coordinated with a specialist team for the POTS / dysautonomia / MCAS triad, and includes evaluation and referral planning for craniocervical and atlantoaxial instability (CCI / AAI).

Care here is led by Dr. Rowan V. Paul, MD — Assistant Professor at Dartmouth’s Geisel School of Medicine and Fellowship Site Director of the Stanford Healthcare Primary Care Sports Medicine Fellowship, with more than fifteen years practicing image-guided regenerative orthopedics.

MORE ABOUT DR. PAUL

REQUEST AN EVALUATION

Educational information, not medical advice or a diagnosis. Care is individualized; not every treatment is right for every patient, and results vary.